LON:FBT First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT) Share Price, News & Analysis → They say it’s ‘unstoppable’ – How I made 43,509% (From Investing Daily) (Ad) Free FBT Stock Alerts GBX 1,409.40 +21.40 (+1.54%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range 1,395.44▼ 1,409.4050-Day Range 1,388▼ 1,495.6052-Week Range 1,313.70▼ 1,580.60Volume918 shsAverage Volume1,225 shsMarket Capitalization£4.16 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Get First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation alerts: Email Address Ad Investing DailyThey say it’s ‘unstoppable’ – How I made 43,509% Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. About First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock (LON:FBT)Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content. The company operates under the brand name of Blackbird. The company was founded in 1998 and is based in London, the United Kingdom.Read More FBT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FBT Stock News HeadlinesApril 22, 2024 | finance.yahoo.comNet Asset Values(s)January 22, 2024 | finance.yahoo.comNet Asset Value(s)April 27, 2024 | Investing Daily (Ad)They say it’s ‘unstoppable’ – How I made 43,509% Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.September 27, 2023 | benzinga.comFirst Trust Energy Infr: Dividend InsightsMay 11, 2023 | uk.investing.comLyxor NYSE Arca Gold BUGS (DR) UCITS ETF (CD91)February 21, 2023 | money.usnews.comFirst Trust NYSE Arca Biotech ETFFebruary 24, 2022 | apnews.comCORRECTING and REPLACING First Trust Advisors L.P. Announces Distribution for First Trust Enhanced Short Maturity ETFSee More Headlines Receive FBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorComputer and Technology Industry Software - Application Sub-IndustryN/A Current SymbolLON:FBT CUSIPN/A CIKN/A Webwww.forbidden.co.uk Phone+44-20-88797245FaxN/AEmployees20Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.04 Current Ratio9.42 Quick Ratio9.27 Sales & Book Value Annual Sales£870,310.00 Price / Sales4,785.17 Cash FlowGBX 397.68 per share Price / Cash Flow3.54 Book ValueGBX 1.90 per share Price / Book741.79Miscellaneous Outstanding Shares295,486,016Free FloatN/AMarket Cap£4.16 billion OptionableNot Optionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Ian McDonough (Age 47)CEO & Director Mr. Stephen B. StreaterFounder, Director of R&D and Exec. DirectorMr. Stephen James White (Age 48)Chief Operating & Financial Officer and Director Adrian LambertMarketing DirectorRachel DarcySales DirectorKey CompetitorsSophos Group plc (SOPH.L)LON:SOPHBlue Prism GroupLON:PRSMKape TechnologiesLON:KAPEKainos GroupLON:KNOSAvastLON:AVSTView All Competitors FBT Stock Analysis - Frequently Asked Questions How have FBT shares performed in 2024? First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation's stock was trading at GBX 1,526.10 at the start of the year. Since then, FBT stock has decreased by 7.6% and is now trading at GBX 1,409.40. View the best growth stocks for 2024 here. What other stocks do shareholders of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation own? Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation investors own include Taylor Wimpey (TW), Johnson & Johnson (JNJ), Weyerhaeuser (WY), AbbVie (ABBV), ARK Innovation ETF (ARKK), Alibaba Group (BABA), Bristol-Myers Squibb (BMY), Global X Robotics & Artificial Intelligence Thematic ETF (BOTZ) and Caterpillar (CAT). How do I buy shares of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation? Shares of FBT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:FBT) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.